Please login to the form below

Not currently logged in
Email:
Password:

PAD

This page shows the latest PAD news and features for those working in and with pharma, biotech and healthcare.

Astellas makes another gene therapy play with Juventas deal

Astellas makes another gene therapy play with Juventas deal

and late-stage peripheral artery disease (PAD).

Latest news

More from news
Approximately 1 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    Mylan, the global healthcare company, has chosen the UK for the launch pad of its much-anticipated biosimilar version of the Sanofi blockbuster Lantus (insulin glargine), which it hopes will become

  • Deal Watch March 2016 Deal Watch March 2016

    Padlock's technology targets autoimmune disorders with protein/peptidyl arginine deiminase (PAD) inhibitors and offers the potential to prevent disease development in patients with early stage disease. ... Protein/peptidyl arginine deiminase (PAD)

  • Pharma deals in August 2015 Pharma deals in August 2015

    with two thirds voting in favour, which provides a firm launch pad for a formal offer.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics